David de Weese
Vorsitzender bei Capacitor Sciences, Inc.
Profil
David H.
de Weese was the founder of M6 Pharmaceuticals, Inc. (founded in 1993) where he held the title of President & Chief Executive Officer.
He currently holds the position of Chairman at Capacitor Sciences, Inc., Director at GWG Life LLC, and Director at Cryscade, Inc. Mr. de Weese has previously held positions as Chief Executive Officer at Machine Intelligence Corp.
(1983-1986), President & Chief Executive Officer at Cygnus Therapeutic Systems (1986-1992), President & Chief Executive Officer at Siga Pharmaceuticals, Inc. (1993-1997), President & Chief Executive Officer at Silicon Valley Software Group, Independent Director at GWG Holdings, Inc. (2019-2022), Independent Director at Orphan Synergy Europe-Pharma SA, Director at The Olana Partnership, Director at OSE Immunotherapeutics SA (2014-2017), and General Partner at Paul Capital Partners LP (1995-2010).
Mr. de Weese obtained his undergraduate degree from Stanford University in 1963 and his MBA from Harvard Business School in 1965.
Aktive Positionen von David de Weese
| Unternehmen | Position | Beginn |
|---|---|---|
| Cryscade, Inc. | Direktor/Vorstandsmitglied | - |
Capacitor Sciences, Inc.
 Capacitor Sciences, Inc. Alternative Power GenerationUtilities Capacitor Sciences, Inc. transforms energy storage. It utilizes crystalline materials providing 10 times the energy and 100 times the power density of Li-ion batteries. The firm economically stores solar power. The company was founded by Pavel lazarev and is headquartered in Menlo Park, CA. | Vorsitzender | - |
GWG Life LLC
 GWG Life LLC Life/Health InsuranceFinance GWG Life LLC engages in the provision of life insurance services. Through LifeCareXchange, it offers protection, income, LTC benefit, and lump sump benefits. The company was founded in 2006 and is headquartered in Minneapolis, MN. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von David de Weese
| Unternehmen | Position | Ende |
|---|---|---|
| GWG HOLDINGS, INC. | Direktor/Vorstandsmitglied | 17.11.2022 |
| OSE IMMUNOTHERAPEUTICS | Direktor/Vorstandsmitglied | 14.06.2017 |
| Siga Pharmaceuticals, Inc. | Vorstandsvorsitzender | 01.12.1997 |
Cygnus Therapeutic Systems
 Cygnus Therapeutic Systems Medical SpecialtiesHealth Technology Cygnus Therapeutic Systems develops and manufactures non-invasive glucose monitoring devices. The private company is based in Redwood City, CA. | Vorstandsvorsitzender | 01.01.1992 |
| Machine Intelligence Corp. | Vorstandsvorsitzender | 01.01.1986 |
Ausbildung von David de Weese
| Stanford University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| Private Unternehmen | 12 |
|---|---|
Paul Capital Partners LP
 Paul Capital Partners LP Investment ManagersFinance Founded in 1991 by Philip Paul, Paul Capital Partners LP is a private equity firm located in San Francisco with additional offices in New York City, Hong Kong, London, Paris and São Paulo. | Finance |
Cygnus Therapeutic Systems
Cygnus Therapeutic Systems Medical SpecialtiesHealth Technology Cygnus Therapeutic Systems develops and manufactures non-invasive glucose monitoring devices. The private company is based in Redwood City, CA. | Health Technology |
Orphan Synergy Europe-Pharma SA
 Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France. | Health Technology |
| Cryscade, Inc. | |
Capacitor Sciences, Inc.
Capacitor Sciences, Inc. Alternative Power GenerationUtilities Capacitor Sciences, Inc. transforms energy storage. It utilizes crystalline materials providing 10 times the energy and 100 times the power density of Li-ion batteries. The firm economically stores solar power. The company was founded by Pavel lazarev and is headquartered in Menlo Park, CA. | Utilities |
| The Olana Partnership | |
| Machine Intelligence Corp. | |
GWG Holdings, Inc.
 GWG Holdings, Inc. Life/Health InsuranceFinance GWG Holdings, Inc. engages in the business of life insurance secondary market. It offers liquidity solutions and services for the owners of illiquid investments. It operates through the following segments: Secondary Life Insurance, Beneficient, and Corporate and Other. The Secondary Life Insurance segment seeks to earn non-correlated yield from the portfolio of life insurance policies. The Beneficient segment includes assets and operations of Ben LP and its subsidiaries. The company was founded by Jon R. Sabes, Paul A. Siegert, and Steven F. Sabes in February 2006 and is headquartered in Dallas, TX. | Finance |
M6 Pharmaceuticals, Inc.
 M6 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology M6 Pharmaceuticals, Inc. manufactures and sells pharmaceutical products. The private company is based in New York. The American company was founded by David H. de Weese. | Health Technology |
| Siga Pharmaceuticals, Inc. | |
| Silicon Valley Software Group | |
GWG Life LLC
GWG Life LLC Life/Health InsuranceFinance GWG Life LLC engages in the provision of life insurance services. Through LifeCareXchange, it offers protection, income, LTC benefit, and lump sump benefits. The company was founded in 2006 and is headquartered in Minneapolis, MN. | Finance |
